K. Csillag et al. / Tetrahedron: Asymmetry 23 (2012) 144–150
149
(1H, d, J = 5.8 Hz), 2.44–2.51 (1H, m), 2.55–2.61 (1H, m), 2.95 (1H,
dd, J = 5.4, 10.0 Hz), 3.39 (1H, s), 3.56–3.62 (1H, m). 13C NMR
(CDCl3) d (ppm): 24.10, 25.26, 25.63, 26.07, 27.59, 27.79, 34.34,
35.70, 38.61, 39.63, 40.78, 48.38, 51.11, 56.31, 70.49, 74.23. IR
4.8. General procedure for the synthesis of oxazolidines (+)-11
and (ꢀ)-15
At first, 5 mL of 35% aqueous formaldehyde was added to a solu-
tion of (+)-9 or (+)-14 (0.43 mmol) in 2 mL of Et2O. The mixture
was stirred at room temperature for 1 h, then made alkaline with
10% aqueous KOH and extracted with Et2O (3 ꢁ 15 mL). The com-
bined organic phase was dried (Na2SO4) and evaporated. The crude
product was purified by column chromatography [(+)-11: n-hex-
ane/EtOAc = 4:1, (ꢀ)-15: n-hexane/EtOAc = 3:2].
(KBr, cmꢀ1
)
m
= 3366, 2927, 1453, 1067, 893. Anal. Calcd for
C16H29NO2 (267.22): C, 71.86; H, 10.93; N, 5.24. Found: C, 71.68;
H, 10.77; N, 5.46.
4.5.2. (1R,2R,3S,5R)-3-Pentan-3-ylamino-2-hydroxymethyl-6,6-
dimethylbicyclo[3.1.1]heptan-2-ol (+)-8
Compound (+)-8: 0.02 g (18%); yellow oil; ½a D20
¼ þ5:0 (c 0.125,
ꢂ
MeOH); 1H NMR (CDCl3) d (ppm): 0.87–0.95 (9H, m), 1.25–1.31
(5H, m), 1.35–1.60 (4H, m), 1.87–1.92 (1H, m), 2.14–2.21 (2H,
m), 2.51–2.61 (2H, m), 2.97 (1H, dd, J = 5.4, 10.1 Hz), 3.42 (2H, s).
13C NMR (CDCl3) d (ppm): 9.49, 10.31, 24.17, 26.12, 26.34, 27.61,
27.79, 29.86, 38.80, 40.82, 48.61, 51.89, 60.01, 70.55, 74.64. IR
4.8.1. [(1R,2R,6S,8R)-5-Benzyl-9,9-dimethyl-3-oxa-5-
azatricyclo[6.1.1.02,6]dec-2-yl]methanol (+)-11
Compound (+)-11: 0.12 g (97%); oil; ½a D20
¼ þ3:0 (c 0.125,
ꢂ
MeOH); 1H NMR (DMSO-d6) d (ppm): 0.81 (3H, s), 1.21 (3H, s),
1.73–1.86 (3H, m), 1.91–2.09 (3H, m), 2.68 (1H, d, J = 7.9 Hz),
3.28–3.40 (2H, m), 3.53 (1H, dd, J = 5.3, 11.8 Hz), 3.91 (1H, d,
J = 13.2 Hz), 3.98 (1H, s), 4.31 (1H, s), 4.63 (1H, t, J = 7.4 Hz),
7.21–7.34 (5H, m). 13C NMR (DMSO-d6) d (ppm): 23.14, 24.12,
27.03, 32.32, 37.24, 40.25, 45.19, 54.76, 57.16, 65.33, 84.39,
(KBr, cmꢀ1
)
m
= 3420, 2924, 1630, 1462, 1065. Anal. Calcd for
C15H29NO2 (255.22): C, 70.54; H, 11.45; N, 5.48. Found: C, 70.37;
H, 11.27; N, 5.57.
88.24, 126.88, 128.18, 128.28. IR (KBr, cmꢀ1
) m = 3441, 2925,
1955, 1808, 1604, 1453, 1071, 698. Anal. Calcd for C18H25NO2
(287.19): C, 75.22; H, 8.77; N, 4.87. Found: C, 75.07; H, 8.65; N,
4.99.
4.6. Preparation of (1R,2R,3S,5R)-3-benzylamino-2-
hydroxymethyl-6,6-dimethylbicyclo[3.1.1]heptan-2-ol (+)-9
To a mixture of (ꢀ)-4 (0.20 g, 0.9 mmol) and Et3N (0.18 g,
1.8 mmol) in dry EtOH (15 mL), benzaldehyde (0.10 g, 0.95 mmol)
was added, and the mixture was stirred for 2 h at room tempera-
ture. After evaporation of the solvent, the residue was dissolved
in dry EtOH (15 mL), after which NaBH4 (0.068 g, 1.8 mmol) was
added portionwise. The reaction mixture was stirred for 24 h at
room temperature, the solvent was then removed and the residue
was dissolved in H2O and extracted with CHCl3 (3 ꢁ 20 mL). The
combined organic layer was dried (Na2SO4) and evaporated. The
crude product was purified by column chromatography (CHCl3/
MeOH = 9:1). Compound (+)-9: 0.20 g (81%); colourless crystalline
4.8.2. [(1R,2R,6S,8R)-5,9,9-Trimethyl-3-oxa-5-
azatricyclo[6.1.1.02,6]dec-2-yl]methanol (ꢀ)-15
Compound (+)-15: 0.03 g (41%); colourless crystalline powder,
mp 44–46 °C; ½a 2D0
ꢂ
¼ ꢀ11:0 (c 0.125, MeOH); 1H NMR (CDCl3) d
(ppm): 0.86 (3H, s), 1.29 (3H, s), 1.17–1.85 (3H, m), 1.92–1.98
(1H, m), 2.00–2.08 (1H, m), 2.12–2.20 (1H, m), 2.28 (1H, t,
J = 5.5 Hz), 2.33 (3H, s), 2.37–2.43 (1H, m), 3.56 (1H, d,
J = 11.5 Hz), 3.65 (1H, d, J = 11.5 Hz), 3.99 (1H, s), 4.60 (1H, s). 13C
NMR (CDCl3) d (ppm): 23.77, 24.68, 27.32, 31.40, 36.60, 37.96,
40.98, 45.28, 60.38, 66.34, 86.27, 89.37. IR (KBr, cmꢀ1
) m = 3425,
powder, mp 74–78 °C, ½a D20
ꢂ
¼ þ10:0 (c 0.125, MeOH); 1H NMR
2926, 1458, 1067. Anal. Calcd for C12H21NO2 (211.16): C, 68.21;
H, 10.02; N, 6.63. Found: C, 68.49; H, 10.15; N, 6.57.
(CDCl3)
d (ppm): 0.90 (3H, s), 1.25 (3H, s), 1.32 (1H, d,
J = 10.3 Hz), 1.46 (1H, ddd, J = 2.6, 5.7, 13.7 Hz), 1.88–1.92 (1H,
m), 2.15 (1H, t, J = 5.9 Hz), 2.18–2.24 (1H, m), 2.48–2.55 (1H, m),
3.02 (1H, dd, J = 5.7, 9.9 Hz), 3.43 (2H, dd, J = 10.8, 24.2 Hz), 3.90
(2H, s), 7.27–7.37 (5H, m). 13C NMR (CDCl3) d (ppm): 24.07,
27.63, 27.78, 37.68, 38.53, 40.77, 48.84, 52.97, 53.62, 70.70,
4.9. Preparation of (1R,2R,3S,5R)-3-benzyl(methyl)amino-2-
hydroxymethyl-6,6-dimethylbicyclo[3.1.1]heptan-2-ol (+)-12
To a stirred suspension of LiAlH4 (0.48 g, 12.63 mmol) in dry
THF (90 mL), a solution of (+)-11 (1.45 g, 5.05 mmol) in THF
(15 mL) was added at 0 °C. The reaction mixture was refluxed for
1.5 h, and a mixture of H2O (0.5 mL) and THF (25 mL) was then
added dropwise with cooling. The inorganic material was filtered
off and washed with THF. The filtrate was dried (Na2SO4) and evap-
orated. The crude product was purified by column chromatography
(toluene/EtOH = 4:1). Compound (+)-12: 0.56 g (38%); oil;
74.77, 127.68, 128.42, 128.81. IR (KBr, cmꢀ1
) m = 3345, 2904,
1935, 1862, 1798, 1740. Anal. Calcd for C17H25NO2 (275.39): C,
74.14; H, 9.15; N, 5.09. Found: C, 73.97; H, 8.99; N, 5.19.
4.7. Preparation of (1R,2R,3S,5R)-3-dibenzylamino-2-
hydroxymethyl-6,6-dimethylbicyclo[3.1.1]heptan-2-ol (+)-10
½
a 2D0
ꢂ
¼ þ8:0 (c 0.125, MeOH); 1H NMR (CDCl3) d (ppm): 0.91 (3H,
To a solution of (+)-9 (0.10 g, 0.36 mmol) and Et3N (0.11 g,
1.1 mmol) in dry MeCN (5 mL), benzyl bromide (0.065 g,
0.42 mmol) was added. When the reaction was complete (moni-
tored by means of TLC), the mixture was evaporated to dryness,
and the residue was dissolved in H2O (3 mL) and extracted with
CHCl3 (3 ꢁ 5 mL). The combined organic layer was dried (Na2SO4)
and evaporated. The crude product was purified by column chro-
matography (n-hexane/EtOAc = 2:1). Compound (+)-10: 0.04 g
s), 1.26 (3H, s), 1.39 (1H, d, J = 10.6 Hz), 1.96–2.11 (3H, m), 2.15
(1H, t, J = 5.5 Hz), 2.21–2.27 (1H, m), 2.43 (3H, s), 3.20 (1H, s),
3.32 (2H, s), 3.66 (1H, d, J = 13.1 Hz), 3.88 (1H, d, J = 13.1 Hz),
7.27–7.37 (5H, m). 13C NMR (CDCl3) d (ppm): 23.98, 24.59, 27.19,
27.84, 38.50, 39.65, 40.74, 46.87, 58.40, 61.57, 70.22, 77.42,
127.78, 128.75, 129.23. IR (KBr, cmꢀ1
) m = 3433, 2913, 1946,
1602, 1457, 700. Anal. Calcd for C18H27NO2 (289.41): C, 74.70; H,
9.40; N, 4.84. Found: C, 74.35; H, 9.06; N, 5.16.
(30%); colourless crystalline powder, mp 128–130 °C;
½
a 2D0
ꢂ
¼
þ11:0 (c 0.125, MeOH); 1H NMR (CDCl3) d (ppm): 0.80 (3H, s),
1.24–1.28 (4H, m, CH3, 1H), 1.47 (1H, d, J = 11.1 Hz), 1.57 (1H, s),
1.99–2.29 (5H, m), 2.98 (2H, s), 3.25 (1H, s), 3.48 (2H, d,
J = 13.0 Hz), 4.06 (2H, s), 7.26–7.35 (10H, m). 13C NMR (CDCl3) d
(ppm): 23.77, 24.91, 27.49, 27.93, 32.53, 38.40, 40.86, 47.48,
4.10. Preparation of (1R,2R,3S,5R)-3-(N-Benzyl-N-
methylamino)-2-benzyloxymethyl-6,6-
dimethylbicyclo[3.1.1]heptan-2-ol (+)-13
54.35, 56.75, 70.10, 77.67, 127.65, 128.84, 129.06. IR (KBr, cmꢀ1
)
A solution of (+)-12 (0.20 g, 0.69 mmol) in THF (5 mL) was
added to a suspension of NaH (60% in mineral oil; 0.034 g,
0.87 mmol) in THF (3 mL) at 0 °C under an Ar atmosphere. The
m
= 3431, 2921, 1630, 1452, 747. Anal. Calcd for C24H31NO2
(365.51): C, 78.86; H, 8.55; N, 3.83. Found: C, 78.50; H, 8.20; N, 4.02.